Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Levinson building?

Executive Summary

As part of the $200 mil. settlement between Genentech and the University of California-San Francisco over patents on recombinant human growth hormone, Genentech will contribute $50 mil. towards the construction of the first biological sciences research building on the new UCSF Mission Bay campus. Genentech will have the rights to name the building. The agreement provides $35 mil. in additional funding to UCSF and $30 mil. to the University of California general fund. Five researchers will share the remaining $85 mil. Genentech CEO Arthur Levinson, PhD, was a postdoctoral fellow at UCSF
UsernamePublicRestriction

Register

PS035218

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel